D. Ruano et al., MOLECULAR CHARACTERIZATION OF TYPE-I GABA(A) RECEPTOR COMPLEX FROM RAT CEREBRAL-CORTEX AND HIPPOCAMPUS, Molecular brain research, 25(3-4), 1994, pp. 225-233
The molecular composition of the native gamma-aminobutyric acid(A) (GA
BA(A)) receptor complex is actually unknown. In the present communicat
ion we report a novel approach to characterize the minimal molecular c
onformation of the native GABA(A) receptor complex. This novel approac
h is based on the combination of subunit specific antibodies and speci
fic H-3-labeled ligands in immunoprecipitation experiments. We have de
termined the presence of beta(1/2) and gamma(2) subunits in the Type I
GABA(A) receptor complex, from rat cerebral cortex and hippocampus, b
y using two antibodies, the monoclonal 62-3G1 (specific for beta(2/3))
and the polyclonal anti-gamma(2) (to the large intracellular loop of
the gamma(2) short form) together with the Type I-specific ligand [H-3
]zolpidem. The association of gamma(2) and beta(2/3) subunits with the
GABA(A) receptor complex was also tested using [H-3]flumazenil. The r
esults indicated that both yz and beta(2/3) were the most abundant sub
units associated to either Type I or total benzodiazepine receptors fr
om both cortex and hippocampus. Between 70-80% of Type I or total benz
odiazepine binding activity was immunoprecipitated by either antibody.
In addition, we have also investigated the coexistence of both subuni
ts as part of the same population of Type I GABA(A) receptor complex b
y cross-immunoprecipitation experiments with 62-3G1 and anti-gamma(2).
The results indicated that, in cerebral cortex, both gamma(2) and bet
a(2/3) subunits were part of the same population of Type I receptors.
In hippocampus, an additional 20% of Type I receptors displayed either
gamma(2) or beta(2/3) but not both subunits. On the other hand, a sub
stantial proportion (30% in cortex or 10-20% in hippocampus) of Type I
receptor was not immunoprecipitated by either antibody. Therefore, th
ese population of GABA(A) receptor complex with Type I pharmacology ma
y be constructed by association of subunits others than gamma(2) or be
ta(2/3).